March 20, 2012
-New Assay, Developed in Collaboration with Morphotek, Uses Proprietary Technology-
Concord, CA and Exton, PA, March 20, 2012 – In partnership with Morphotek® Inc., a subsidiary of Eisai Inc., Biocare Medical announced the release of its in vitro diagnostic immunohistochemical (IHC) kit to detect folate receptor alpha (FRalpha) expression in formalin fixed paraffin embedded (FFPE) [...]
Read more
December 19, 2011
Biocare Medical proudly introduces four newly developed horseradish peroxidase (HRP) and alkaline phosphatase (AP) polymer detection systems for horse, cow, pig and sheep tissues. These Mouse-on-Farma and Rabbit-on-Farma HRP and AP polymers are specifically designed to achieve excellent staining quality when using mouse or rabbit primary antibodies. The advanced polymer technology virtually eliminates cross-reactivity to [...]
Read more
December 2, 2011
Enhancing the Multiplex IHC product line, Biocare is pleased to announce the addition of Uro-2™ to our bladder cancer diagnosis and differentiation line. Having a more accessible clinical utility, the Uro-2™ (CK20 + p53) can be used to differentiate urothelial reactive atypia from CIS (carcinoma in situ) in the bladder. For urothelium with cases [...]
Read more
October 26, 2011
Biocare Medical Ranks No. 2781 on the 2011 Inc. 500 | 5000 with Three-Year Sales Growth of 79%
Concord, CA, October 10, 2011 – Biocare Medical ranked No. 2781 in Inc. Magazine’s fifth annual Inc. 500|5000, an exclusive ranking of the nation’s fastest-growing private companies. This represents the third consecutive year that Biocare Medical has [...]
Read more
October 18, 2011
Biocare Medical would like to thank you for making the 37th Annual National Society of Histotechnology in Cincinnati, OH a great meeting! Hundreds of you stopped by our booth to take part of the “HistoFabulous Tour” where you learned about the latest IHC and ISH techniques and products.
After getting your Passport stamped and picture taken [...]
Read more
June 20, 2011
Biocare Medical is proud to announce the launch of a mouse monoclonal PAX8 antibody. Unlike current existing PAX8 polyclonals, the PAX8 mouse clone [BC12] has been designed for specific epitope targeting. The monoclonal PAX8 does not stain B-cells, cells of pancreatic origin or neuroendocrine cells of the stomach or colon. This antibody also has lower [...]
Read more
April 8, 2011
Biocare Medical is proud to announce the launch of the PulmoPanel™ Multiplex IHC to clearly differentiate between adenocarcinoma (LADC) and squamous cell carcinoma (SqCC) of the lung with 97% specificity and 93% sensitivity. This Multiplex IHC contains six antibodies (TTF-1, Napsin A, p63, TRIM29, Desmoglein 3 and CK5), and aids in the critical differentiation [...]
Read more
Morphotek®, Inc., a subsidiary of Eisai Inc., announced today that it has entered into a collaboration and license agreement with Biocare Medical, LLC. Under the agreement, the parties will collaborate to develop and commercialize an immunohistochemical (IHC) diagnostic kit utilizing Morphotek’s proprietary monoclonal antibody to specifically detect human folate receptor alpha (FRA) with Biocare’s intelliPATH™ [...]
Read more
